InsightRX specializes in model-informed precision dosing and clinical decision support systems to enhance patient outcomes in healthcare. The company provides real-time clinical analytics and therapeutic methodologies for various medical disciplines.

InsightRX

InsightRX empowers life science and provider healthcare organizations to individualize treatment from clinical development to the point of care.

Comet Labs

OSF Ventures

FundersClub

GreatPoint Ventures

Leawood Venture Capital

Rock Health Capital

OSF Healthcare System

HealthX Ventures

Premier

The InsightRX team is looking forward to the ASHP Midyear 2023 conference in Anaheim, California, from Dec. 3-7. Just in time for #ASHP23, we’re announcing three major enhancements to our current precision dosing solutions based on recent scientific and technological breakthroughs.

☑ A more accurate vancomycin PK dosing model for adult patients
☑ An exclusive MIPD feature enabling more accurate predictions
☑ A new model for adult vancomycin patients with Class III obesity

Drop in to visit us at Booth 566 during #ASHP23 to meet the team and discuss how these exciting new breakthroughs will enable clinicians to provide vancomycin patients with highly accurate and individualized doses to ensure safety and efficacy: https://bit.ly/3sULQaY | #PrecisionMedicine #PrecisionDosing #Vancomycin #ImagineThePossiblities

New laws leave consumers unprotected against third parties accessing their genetic data, according to the authors of an analysis published by JAMA Network Open.

“The bottom line is that ultimately more needs to be done in this space to protect consumers, according to the commentary. The enacted legislation does not robustly address the fact that third parties, particularly law enforcement and insurers, can still access and use consumer genetic data.”

https://bit.ly/47ixcci | #GeneticData #HealthData Applied Clinical Trials Magazine MJH Life Sciences®

Mark your calendar for this upcoming ASCPT Webinar on Friday, Dec 8, 2023, at 2:00 PM ET titled, “Establishing a Framework for Precision Dosing in a Clinical Trial.”

The InsightRX team will highlight two real-life examples:
1️⃣ The use of precision dosing to enable conditioning prior to gene therapy
2️⃣ Precision dosing as a method for selecting the right dose in a vulnerable patient population

Register now to discover how precision dosing and advanced conditioning methods in easy-to-use software enable more effective, personalized treatments.

https://bit.ly/3uojkyJ | #PrecisionMedicine #PrecisionDosing #ClinicalTrials #ASCPT American Society for Clinical Pharmacology & Therapeutics

The InsightRX Team would like to wish you a safe and Happy Thanksgiving! We are grateful for all the clinicians working today and every day to keep their patients safe. #HappyThanksgiving #Grateful #Thankful

Triazole antifungal medications, such as fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole, are frequently employed in clinical settings for the treatment of invasive fungal infections. The variability in their pharmacokinetics, documented drug interactions, and established connections between drug exposure and response necessitate the need for therapeutic drug monitoring (TDM) for most triazole antifungals.

This article, representing the Society of Infectious Diseases Pharmacists (SIDP), presents an in-depth discussion of the pharmacokinetic principles and pharmacodynamic targets associated with commonly used triazole antifungals, highlighting the rationale for incorporating TDM for each of these agents.

For example, the consensus guidelines listed in Table 1 suggest Bayesian MIPD should be used for adjusting voriconazole.

Read more: https://bit.ly/492qPeO | #AntifungalMedications #Pharmacokinetics #TherapeuticDrugMonitoring

Syapse is a company that provides precision medicine solutions for healthcare providers and researchers.

Syapse

PierianDx is a company focused on genomic informatics and services for personalized medicine.

PierianDx

Translational Software provides pharmacogenomics solutions to personalize medication management.

Translational Software

Rx Studio is a company focused on personalizing pharmacological interventions through a cloud computing platform.

Rx Studio

InsightRX is a software platform that incorporates quantitative pharmacology and machine learning to provide individualized understanding of a patient’s response to treatment. It delivers technology in the form of easy-to-use clinical decision support tools at the point-of-care to guide treatment decision-making.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 1, 2024 5:32 AM	1974f449
public peers	general	Oct 2, 2024 3:29 PM	0ae5d1c4
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Oct 8, 2024 10:19 AM	b80d7ad3
company summary	general
signals	general	Oct 2, 2024 3:29 PM	36704932
crunchbase trigger	general
crunchbase profile	general
li profile	general	Mar 1, 2024 5:32 AM	c11bad09
translate crunchbase fundingrounds	general
peers	general	Oct 2, 2024 3:29 PM	4e6e05c9
news basic	general	Oct 2, 2024 3:29 PM	0212387f
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:INSIGHT-RX

InsightRX